Biomedical Research, Inc. (ABR) is a full service
contract research organization.
||Alere is focused on combining diagnostics with health management services to help determine the best course of treatment.
||BioWa is focused on research and development of fucose-free monoclonal antibodies that demonstrate increased antibody-dependent cellular cytotoxicity (ADCC).
Squibb is a leading diversified worldwide health
and personal care company whose principal businesses
are medicines, beauty care, nutritionals, and
||Celator Pharmaceuticals is focused on the development of synergistic ratios of drugs to improve therapies to treat cancer.
is one of the world's largest and most comprehensive
drug development services companies.
Sciences is a full-line wound management & skin
care products company.
||Eleison Pharmaceuticals is focused on the acquisition, development, and commercialization of clinical stage drug candidates for orphan indications.
||Laureate Pharma is focused on providing contract development and cGMP manufacturing services for mammalian cell based monoclonal antibody and recombinant protein production.
||Lexicon Pharmaceuticals is focused on the discovery and development of drug candidates identified using mouse gene knockouts. These drug candidates target a variety of diseases across several therapeutic areas.
||Onconova Therapeutics is focused on the discovery and development of drugs for treating cancer and radiation injury.
|PharmaNet Development Group
||PharmaNet Development Group is focused on providing drug development services to pharmaceutical, biotechnology, generic drug, and medical device companies.
||Pharmasset is focused on the research and development of drugs to treat patients with viral infections.
Pharmaceuticals is involved in the production and
marketing of approved generic pharmaceuticals.
||Soligenix focused on the development of products to treat life-threatening side effects of cancer treatment, serious gastrointestinal diseases, and vaccines for selected bioterrorism agents.
||VIA Pharmaceuticals is focused on the development of small-molecule drugs to treat cardiovascular and metabolic disease.